Chromogranin-A
mammalian protein found in Homo sapiens
Chromogranin-A (CgA) or parathyroid secretory protein 1 is encoded in the human by the gene CHGA. Cga is a member of the granin family of neuroendocrine secretory proteins. As such, it is located in secretory vesicles of neurons and endocrine cells such as islet beta cell secretory granules in the pancreas.
Tissue distribution
Examples of cells producing chromogranin-A (CgA) are chromaffin cells of the adrenal medulla, paraganglia, enterochromaffin-like cells and beta cells of the pancreas. It is present in islet beta cell secretory granules. chromogranin-A (CgA)+ Pulmonary neuroendocrine cells account for 0.41% of all epithelial cells in the conducting airway, but are absent from the alveoli.
Function
Chromogranin-A is the precursor to several functional peptides including vasostatin-1, vasostatin-2, pancreastatin, catestatin and parastatin. These peptides negatively modulate the neuroendocrine function of the releasing cell (autocrine) or nearby cells (paracrine).
Chromogranin-A induces and promotes the generation of secretory granules such as those containing insulin in pancreatic islet beta cells. Chromogranin-A is also present in the secretory granules of chromaffin cells and is co-released with catecholamines, playing a role in regulating their release.
Clinical significance
Chromogranin-A is elevated in pheochromocytomas.
“Chromogranin-A” enters the record as mammalian protein found in Homo sapiens. Crown Archives preserves that source wording while asking what Chromogranin-A, mammalian and protein can confirm, complicate or overturn.
Why this record matters
“Chromogranin-A” is worth following because a concise public description often conceals a longer documentary argument. Here, Chromogranin-A, mammalian and protein provides the most credible route into that argument.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Apr 6, 2026. The linked authority identifier is Q3698322.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Chromogranin-A”, its source revision and the description used here.
- Expand the search: follow Chromogranin-A primary sources, Chromogranin-A archive and Chromogranin-A research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Chromogranin-A”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Chromogranin-A” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.